Compare WTM & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTM | INDV |
|---|---|---|
| Founded | 1980 | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.7B |
| IPO Year | 1994 | 2014 |
| Metric | WTM | INDV |
|---|---|---|
| Price | $2,144.08 | $37.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.7K | ★ 2.0M |
| Earning Date | 05-07-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.05% | N/A |
| EPS Growth | 379.05 | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | ★ $3,735,000,000.00 | $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $54.72 |
| Revenue Growth | ★ 66.76 | 4.29 |
| 52 Week Low | $1,648.00 | $11.49 |
| 52 Week High | $2,333.00 | $41.00 |
| Indicator | WTM | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 58.25 |
| Support Level | $2,025.76 | $29.71 |
| Resistance Level | $2,236.29 | $37.83 |
| Average True Range (ATR) | 53.43 | 1.15 |
| MACD | 2.84 | -0.32 |
| Stochastic Oscillator | 65.92 | 35.77 |
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations. The company has four reportable segments: Ark/WM Outrigger, HG Global, Kudu and Distinguished.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).